Gu, Yuang https://orcid.org/0009-0000-2773-554X
Chen, Jingqu https://orcid.org/0000-0002-0950-1923
Wang, Zhaoran https://orcid.org/0000-0002-3246-4737
Liu, Chang https://orcid.org/0000-0002-2888-6718
Wang, Tianzheng https://orcid.org/0000-0001-8100-3577
Kim, Chan-Jin
Durikova, Helena https://orcid.org/0000-0001-6613-9177
Fernandes, Soraia
Johnson, Darryl N. https://orcid.org/0000-0003-3205-0371
De Rose, Robert https://orcid.org/0000-0003-4316-3910
Cortez-Jugo, Christina
Caruso, Frank https://orcid.org/0000-0002-0197-497X
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (GNT2016732)
Materials Characterisation and Fabrication Platform Victorian State Government, Australia Cumming Global Centre for Pandemic Therapeutics
Article History
Received: 30 April 2024
Accepted: 25 October 2024
First Online: 8 November 2024
Competing interests
: F.C., J.C., Y.G., and C.C.-J. have filed a patent application for this technology. F.C. is a shareholder of Messenger Bio Pty Ltd. The remaining authors declare no competing interests.